Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Neoss, Inc. is celebrating the launch of NeoGenix XPtm

WOODLAND HILLS, Calif., Oct. 25, 2021 /PRNewswire/ -- Following the successful and well-received Allograft line, Neoss is excited to announce the addition of NeoGenix XPtm this autumn to our existing product portfolio. NeoGenix XPtm is a safe and clinically proven natural bone substitute, that closer resembles natural bone than those of synthetic materials, such as hydroxyapatite or tricalcium phosphate.

Surface roughness affects cellular response, enhancing cell adhesion and proliferation and possibly other markers of expression of cell phenotype, like production of collagen type I, osteocalcin, extracellular matrix, and mineralized material.

Discover more here

"Being a strong partner to our customers has always been important and offering more in terms of total package solutions. NeoGenix XPtm is an important addition to this and strengthens not only the bone regeneration portfolio but will allow us to serve our customer even better!" ?Dr Robert Gottlander, Neoss CEO

This exciting product line will add new dimensions to Neoss existing Bone Regeneration offering, providing an enhanced offering of Bone materials and membranes.

Neoss maintains its clear focus on innovation and has a continuous plan of new market leading product solutions that will be presented over the next few years. All with the same target of introducing smart products that are intuitively easy to use with Intelligent Simplicity.  

Be sure to stay updated on these exciting releases by signing up to our newsletter here: https://www.neoss.com/en-us/contact

Connect with your local Neoss sales representative or call 866-626-3677 to explore how we best can help you.

About Neoss® 

Founded in 2000, by a professor of prosthodontics and a specialist engineer, Neoss® offers intelligent dental solutions that are intuitively simple to use. The company's products are designed to allow dental professionals to provide reliable and cost-effective treatments to their patients with excellent long-term results.  Leading with innovation and integrity, Neoss® develops smart treatment solutions and works closely with each practice to drive Intelligent Simplicity, making the complex less complicated.  Headquartered in Harrogate, UK, with research and development based in Gothenburg, Sweden, the company has established a global footprint with long-standing presence in key markets. To find out more about visit https://www.neoss.com/en-us


These press releases may also interest you

at 07:05
Mirion Technologies, Inc. ("Mirion") ("Company"), a global provider of detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that it had completed the acquisition of...

at 07:05
WeCommerce Holdings Ltd. ("WeCommerce" or the "Company") , a leading provider of ecommerce enablement software and tools for merchants, is pleased to announce the promotion of Alex Persson to Chief Executive Officer and the appointment of Chris...

at 07:05
Marqeta , the global modern card issuing platform, today announced a partnership with First National Bank of Omaha (FNBO), expanding its ecosystem of partners that enable its customers to launch modern credit card programs. Consumer demand for...

at 07:05
EO Charging ("EO"), a leading UK-based provider of technology-enabled turnkey solutions for electric vehicle ("EV") fleets, today announced its appointment of Mark Joseph as Chairman of the Board upon completion of EO's business combination with...

at 07:05
Arthur D. Little (ADL) has launched a new report which examines how artificial intelligence (AI) can be used to its full potential in the context of business decision making. The report ? ?From Insight to Impact' looks at how companies can use AI...

at 07:05
ZZ Biotech, a clinical stage biopharmaceutical company developing the experimental drug 3K3A-APC for some of the biggest unmet needs in stroke, neurodegenerative disease and chronic wound healing, today announced that the first patients have been...

News published on 25 october 2021 at 06:02 and distributed by: